Monoclonal antibody which binds to a human-Th2-specific protein and hybridoma
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 26, 2000
Issued Date -
N/A
app pub date -
Jan 10, 2000
filing date -
Jun 5, 1996
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present specification provides a means for specifying the condition and type of immune-related diseases on the basis of knowledge about the polarization of the distribution of helper T-cell subsets Th1 and Th2. More specifically, the gene (B19), specific only to the human Th2, is prepared by a subtraction method. A human-Th2-specific protein which the gene encodes is produced by recombinant methods, and a monoclonal antibody against the Th2-specific protein and a hybridoma which produces the monoclonal antibody is provided.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully